Singireddy, Shreya
Tully, Andy
Galindo, Javier
Ayares, David
Singh, Avneesh K.
Mohiuddin, Muhammad M. http://orcid.org/0000-0003-4654-783X
Article History
Accepted: 4 October 2023
First Online: 8 November 2023
Declarations
:
: Dr. Ayares is the President and CEO of Revivicor and reports other from Revivicor Inc. and personal fees from Revivicor Inc. In addition, Dr. Ayares has a patent on Multitransgenic pigs for xenotransplantation issued. Dr. Mohiuddin reports research funding and pigs provided by United Therapeutics, Inc. and drugs provided by Eledon Pharmaceuticals, Tonix Pharmaceuticals, and Kiniksa Pharmaceuticals. In addition, Dr. Mohiuddin has a patent pending with Kiniksa Pharmaceuticals on the Use of drug KPL 404 to overcome rejection. The other authors have no disclosures to report.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
: Not applicable.